StockData
Senti Biosciences Holdings, Inc. logo

Senti Biosciences Holdings, Inc. (SNTI) stock

SNTINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.10−0.04 (-28.68%)

Close on Nov 17, 2026Market cap $3.02MP/E –Yield –

Senti Biosciences enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Senti Biosciences's enterprise value was -$1.57M on Nov 11, 2026, against $46.39M a year earlier. Over the last 5 years it ranged from -$55.42M to $46.39M, with a median of -$14.57M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$1.57M-110.4%
2025Dec 31, 2025$15.10M+632.9%
2024Dec 31, 2024$2.06M–
2023Dec 29, 2023-$10.04M–
2022Dec 30, 2022-$53.41M–

More Senti Biosciences figures

See a number that looks wrong?